Ardent Health Inc. (ARDT) Revenue History
Annual and quarterly revenue from 2016 to present
ARDT Revenue Over Time (2016–2025)
ARDT Revenue Growth History
6 of 6 years with positive growth- FY2016 revenue growth
- N/A
- FY2017 revenue growth
- +42.6%
- FY2018 revenue growth
- +38.6%
- FY2022 revenue growth
- +23.3%
- FY2023 revenue growth
- +5.5%
- FY2024 revenue growth
- +10.3%
- FY2025 revenue growth
- +6.0%
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $1.62B | -1.4% |
| Q1 2026 | $1.60B | +7.0% |
| Q4 2025 | $1.61B | -0.1% |
| Q3 2025 | $1.58B | +8.8% |
| Q2 2025 | $1.65B | +11.9% |
| Q1 2025 | $1.50B | +4.0% |
| Q4 2024 | $1.61B | +19.3% |
| Q3 2024 | $1.45B | — |
Multi-year avg. share of annual revenue by fiscal quarter
Revenue Breakdown (FY 2025)
ARDT's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
ARDT Revenue Analysis (2016–2025)
Current Revenue & Growth
As of October 3, 2026, Ardent Health Inc. (ARDT) generated trailing twelve-month (TTM) revenue of $6.41 billion, reflecting slight decline in growth of -1.4% year-over-year. The most recent quarter (Q2 2026) recorded $1.62 billion in revenue, up 1.3% sequentially.
Historical Growth Trajectory
ARDT's historical revenue data shows a 3-year CAGR of +7.2%. Ardent Health Inc.'s highest annual revenue of $6.32 billion was recorded in 2025, an all-time high.
Revenue by Segment
ARDT's revenue is primarily driven by Reportable Segment (100%). With over half of revenue concentrated in Reportable Segment, the company has a focused business model while developing other growth vectors.
Peer Comparison
Compared to Healthcare sector peers — including HCA (+7.3% YoY), THC (+5.4% YoY), and CYH (+77.2% YoY) — ARDT has underperformed the peer group in revenue growth. Compare ARDT vs HCA →
ARDT Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| ARDTCurrent | $6.4B | -1.4% | - | 5.1% | |
 HCA | $75.6B | +7.3% | +8.0% | 15.8% | |
 THC | $21.3B | +5.4% | +3.9% | 16.1% | |
 CYH | $12.5B | +77.2% | +1.2% | -79.4% | |
 UHS | $17.4B | +10.0% | +8.5% | 11.5% | |
 ENSG | $5.1B | +18.9% | +16.1% | 8.4% |
ARDT Historical Revenue Data (2016–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $6.32B | +6.0% | $6.17B | 97.5% | $325.6M | 5.1% |
| 2024 | $5.97B | +10.3% | $4.93B | 82.7% | $405.8M | 6.8% |
| 2023 | $5.41B | +5.5% | $5.27B | 97.4% | $229.5M | 4.2% |
| 2022 | $5.13B | +23.3% | $4.17B | 81.4% | $217.0M | 4.2% |
| 2018 | $4.16B | +38.6% | $4.16B | 100.0% | $149.8M | 3.6% |
| 2017 | $3.00B | +42.6% | $3.00B | 100.0% | $121.8M | 4.1% |
| 2016 | $2.11B | - | $2.11B | 100.0% | $84.8M | 4.0% |
ARDT Chart Terminal
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
Live Breakouts Feed
High-probability breakout stocks crossing their pivot across 5 pattern engines.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
10+ years return with dividends reinvested.
Peer Comparison
Compare growth, multiples, and margins vs sector.
ARDT — Frequently Asked Questions
Quick answers to the most common questions about buying ARDT stock.
Is ARDT's revenue growth accelerating or slowing?
ARDT revenue growth is slowing. TTM revenue is $6.4B, up -1.4% year-over-year — below the 5-year CAGR of N/A. The deceleration suggests maturing end-markets or increased competition.
What is ARDT's revenue history from 2016 to 2026?
Ardent Health Inc. (ARDT) revenue history spans 2016 to 2026. TTM revenue as of 2026 is $6.4B, growing at -1.4% YoY. The 5-year CAGR is N/A. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.
What is ARDT's long-term revenue growth rate (CAGR)?
Ardent Health Inc.'s 5-year revenue CAGR of N/A reflects the variable nature of its business expansion. As of 2026, the current YoY growth rate of -1.4% is below this long-term average. CAGR is the most reliable measure of sustained revenue momentum for ARDT.
Why does ARDT's quarterly revenue fluctuate?
ARDT quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. Ardent Health Inc.'s revenue data from 2016 to 2026 shows full historical quarterly detail on this page.
How is ARDT's revenue distributed by segment?
ARDT reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.
How does ARDT's revenue compare to industry peers?
Ardent Health Inc. (ARDT) with TTM revenue of $6.4B and -1.4% YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.